Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HTR2C | P28335 | 11/20 | 0.59 |
| ▸ | HTR2A | P28223 | 10/20 | 0.59 |
| ▸ | HTR2B | P41595 | 10/20 | 0.59 |
| ▸ | PARP3 | Q9Y6F1 | 1/20 | 0.51 |
| ▸ | PARP1 | P09874 | 4/20 | 0.44 |
| ▸ | CA12 | O43570 | 1/20 | 0.38 |
| ▸ | CA9 | Q16790 | 1/20 | 0.38 |
| ▸ | CHRNB4 | P30926 | 1/20 | 0.36 |
| ▸ | CHRNA3 | P32297 | 1/20 | 0.36 |
| ▸ | PDPK1 | O15530 | 1/20 | 0.36 |
| ▸ | PARP10 | Q53GL7 | 1/20 | 0.36 |
| ▸ | PARP11 | Q9NR21 | 1/20 | 0.36 |
| ▸ | TNKS2 | Q9H2K2 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14889471 | 1.00 | HTR2C (0.59) | HTR2CHTR2AHTR2BPARP3PARP1 | |
| SCHEMBL860175 | 1.00 | HTR2C (0.59) | HTR2CHTR2AHTR2BPARP3PARP1 | |
| SCHEMBL862455 | 1.00 | HTR2C (0.59) | HTR2CHTR2AHTR2BPARP3PARP1 | |
| SCHEMBL2599038 | 1.00 | HTR2C (0.59) | HTR2CHTR2AHTR2BPARP3PARP1 | |
| SCHEMBL852284 | 1.00 | HTR2C (0.59) | HTR2CHTR2AHTR2BPARP3PARP1 | |
| SCHEMBL852283 | 1.00 | HTR2C (0.59) | HTR2CHTR2AHTR2BPARP3PARP1 | |
| SCHEMBL2021580 | 0.86 | PARP3 (0.48) | HTR2CHTR2AHTR2BPARP3PARP1 | |
| SCHEMBL2021581 | 0.86 | PARP3 (0.48) | HTR2CHTR2AHTR2BPARP3PARP1 | |
| SCHEMBL2021584 | 0.86 | PARP3 (0.48) | HTR2CHTR2AHTR2BPARP3PARP1 | |
| SCHEMBL2598912 | 0.81 | CHRNB2 (0.41) | HTR2CHTR2AHTR2BPARP3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2571353-A1 | MODULATORS OF 5-HT RECEPTORS AND METHODS OF USE THEREOF | AbbVie Inc. (US) | 2013-03-27 | — | — | EP | claimed |
| WO-2011146089-A1 | MODULATORS OF 5-HT RECEPTORS AND METHODS OF USE THEREOF | ABBOTT LABORATORIES (US) | 2011-11-24 | — | — | WO | claimed |
| EP-2641907-B1 | Preparation of modulators of 5-HT receptors | ABBVIE INC (US) | 2015-01-28 | — | — | EP | disclosed |
| EP-2571353-A1 | MODULATORS OF 5-HT RECEPTORS AND METHODS OF USE THEREOF | AbbVie Inc. (US) | 2013-03-27 | — | — | EP | disclosed |
| EP-2432783-A1 | MODULATORS OF 5-HT RECEPTORS AND METHODS OF USE THEREOF | Abbott Laboratories (US) | 2012-03-28 | — | — | EP | disclosed |
| WO-2011146089-A1 | MODULATORS OF 5-HT RECEPTORS AND METHODS OF USE THEREOF | ABBOTT LABORATORIES (US) | 2011-11-24 | — | — | WO | disclosed |
| WO-2010135560-A1 | MODULATORS OF 5-HT RECEPTORS AND METHODS OF USE THEREOF | ABBOTT LABORATORIES (US) | 2010-11-25 | — | — | WO | disclosed |